Doxorubicin | Decreased proliferation of sarcoma cells | [26, 57] |
Daunorubicin hydrochloride | Destroyed Dalton’s ascitic lymphoma cells | [52] |
Bleomycin | Accumulated in higher levels at the tumor site | [52] |
Methotrexate | Enhanced antitumor activity against sarcoma | [58] |
5-Fluorouracil | Enhanced drug penetration in the treatment of skin cancer | [59] |
Vincristine | Enhanced antitumor activity against sarcoma | [5] |
Tocotrienol | Enhanced cytotoxicity toward breast cancer cells | [61] |
Curcumin | Enhanced cytotoxic and apoptotic effects toward ovarian cancer cells | [63] |
Curcumin and doxorubicin hydrochloride | Enhanced cytotoxicity toward cervical cancer cells | [64] |
Artemisinin | Cytotoxic toward melanoma cells | [68] |
Tamoxifen citrate | Greater cytotoxicity against breast cancer cell line | [70] |
Mitoxantrone | Greater cytotoxicity against human ovarian cancer and breast cancer cell lines | [71] |
Cisplatin | Enhanced cytotoxicity toward breast cancer cells | [73] |